Advanced Sterilization Products (ASP), a division of Fortive Corporation, has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its new ULTRA GI Cycle. This innovative sterilization cycle is designed specifically for the effective reprocessing of duodenoscopes, a type of endoscope commonly used for diagnostic and therapeutic procedures in the gastrointestinal tract.
The ULTRA GI Cycle utilizes hydrogen peroxide gas plasma sterilization technology, a method known for its efficacy in eliminating a wide range of microorganisms, including those of high concern in medical settings. This sterilization method is touted for its ability to achieve rapid and effective sterilization while minimizing the risks often associated with manual cleaning and traditional sterilization processes.
The announcement marks a significant advancement in the standards of reprocessing medical instruments, reflecting a growing need for innovation in surgical tools that are difficult to sterilize and associated with increased risk of infection. Duodenoscopes, by design, are complex and can pose challenges during reprocessing due to their intricate components, which necessitate precise handling to avoid contamination.
This development comes amid heightened scrutiny from regulatory bodies and healthcare organizations over infection control practices linked to the use of duodenoscopes. Several outbreaks of antibiotic-resistant infections have been linked to the inadequate sterilization of these devices, prompting the need for advanced solutions that ensure patient safety.
The FDA clearance of the ULTRA GI Cycle represents a new milestone in the healthcare industry’s ongoing efforts to enhance the cleaning and reprocessing protocols for endoscopic equipment. ASP’s STERRAD 100NX Sterilizer with ALLClear Technology will now integrate this advanced cycle, promoting more efficient sterilization practices and potentially reducing the incidence of infection in clinical settings.
As hospitals and medical facilities look to bolster their infection prevention strategies, the introduction of innovative solutions such as ASP’s ULTRA GI Cycle is expected to play a crucial role in reshaping sterilization practices and improving patient outcomes in gastrointestinal procedures.
Comments